News Item

Nov 11, 2021
Versantis Selected as One of the Five Leading Companies in the Field of Liposomes

The Science Times featured Versantis as leading innovator in the field of liposomal drug delivery. The publication explains the benefit of liposomal drugs and notes an encouraging 10% growth of the current market by 2025. Liposomal drug formulations have immense potential to transform the pharmaceutical industry and we are proud to be driving change with our innovative liposomes-based technology platform behind our lead candidate VS-01.